Literature DB >> 20075381

Postconditioning: from experimental proof to clinical concept.

Nathan Mewton1, Fabrice Ivanès, Martin Cour, Michel Ovize.   

Abstract

The therapeutic strategies for acute myocardial infarction in the last decade have, among other therapeutic targets, focused on myocardial reperfusion injury, which accounts for a significant part of the final infarct size. Although several experiments in the last 20 years have reported that pharmacological interventions at reperfusion might reduce myocardial reperfusion injury, this could not be consistently confirmed in animal models or human studies. An alternative to chemical modifiers, postconditioning (brief repeated periods of ischemia applied at the onset of reperfusion) is the first method proven to be efficient in different animal models and to be confirmed in a recent human study. This simple method, applied in the first minute of reperfusion, reduces the final infarct size by 30-50%. This review will focus on the postconditioning technique and show how the data from different animal models and experimental settings have advanced our understanding of both the mechanisms and the definition of an accurate protocol that is easily applicable in human patients in the setting of acute myocardial infarction.

Entities:  

Mesh:

Year:  2010        PMID: 20075381     DOI: 10.1242/dmm.004309

Source DB:  PubMed          Journal:  Dis Model Mech        ISSN: 1754-8403            Impact factor:   5.758


  4 in total

1.  Cardioprotection with postconditioning: loss of efficacy in murine models of type-2 and type-1 diabetes.

Authors:  Karin Przyklenk; Michelle Maynard; Dale L Greiner; Peter Whittaker
Journal:  Antioxid Redox Signal       Date:  2010-10-06       Impact factor: 8.401

2.  Ranolazine reduces Ca2+ overload and oxidative stress and improves mitochondrial integrity to protect against ischemia reperfusion injury in isolated hearts.

Authors:  Mohammed Aldakkak; Amadou K S Camara; James S Heisner; Meiying Yang; David F Stowe
Journal:  Pharmacol Res       Date:  2011-06-29       Impact factor: 7.658

Review 3.  Efficacy of cardioprotective 'conditioning' strategies in aging and diabetic cohorts: the co-morbidity conundrum.

Authors:  Karin Przyklenk
Journal:  Drugs Aging       Date:  2011-05-01       Impact factor: 3.923

4.  Phosphomimetic modulation of eNOS improves myocardial reperfusion and mimics cardiac postconditioning in mice.

Authors:  Terrence Pong; Marielle Scherrer-Crosbie; Dmitriy N Atochin; Kenneth D Bloch; Paul L Huang
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.